Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of July 27, 2025 • 4:00 AM ET

Date/Time Source News Release
03/28/2025 09:15 AM EDT ACCESS Newswire Quantum Biopharma's 2024 Financial Statements Show Strong Improvements in Cash, Working Capital, Operating Efficiency and the Removal of Material Uncertainty Related to Going Concern
01/17/2025 07:30 AM EST ACCESS Newswire Quantum Biopharma in Court With Dr. Raza Bokhari on January 24, 2025 Seeking a Court Order to Declare Him to Be a Vexatious Litigant and Other Litigation Updates
01/14/2025 08:30 AM EST ACCESSWIRE Quantum Biopharma Ltd. Now Trading on Upstream Under QNTM
01/07/2025 08:30 AM EST ACCESSWIRE Quantum Biopharma Ltd. Approved to Dual List on Upstream
12/20/2024 07:30 PM EST ACCESSWIRE Quantum Biopharma Announces Closing of Second Tranche
12/20/2024 09:15 AM EST ACCESSWIRE Quantum Biopharma Diversifies Treasury With the Purchase of USD $1,000,000 of Bitcoin (BTC) and Other Cryptocurrencies and to Allow for Future Financings and Other Transactions in Cryptocurrency
12/13/2024 07:00 PM EST ACCESSWIRE Quantum Biopharma Announces Closing of First Tranche
12/10/2024 07:30 AM EST ACCESSWIRE Quantum Biopharma Announces That the Safety Review Committee Recommends Commencing Dosing of Second Cohort in the Phase 1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-MS)
12/05/2024 07:30 AM EST ACCESSWIRE Quantum Biopharma Announces Non-Brokered Private Placement of Convertible Debenture Units for Gross Proceeds of Up to $5 Million
10/29/2024 07:30 AM EDT ACCESSWIRE Quantum Biopharma Announces that Sentinel Dosing has Started for the Phase-1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-Ms) in Australia
Page

Additional News

As of July 27, 2025 • 4:00 AM ET

Date/Time Source News Release
08/12/2024 04:30 PM EDT QM US Market Movers News US Companies Moving the Markets, Evening edition
Mon, Aug 12, 2024 as of 4:00 pm ET
08/12/2024 10:00 AM EDT QM US Market Movers News US Companies Moving the Markets, Morning edition
Mon, Aug 12, 2024 as of 10.00 am ET
08/12/2024 08:30 AM EDT InvestorBrandNetwork InvestorNewsBreaks - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Shareholders Approve Plans for Share Consolidation, Name Change
08/09/2024 04:30 PM EDT QM US Market Movers News US Companies Moving the Markets, Evening edition
Fri, Aug 09, 2024 as of 4:00 pm ET
08/09/2024 10:00 AM EDT QM US Market Movers News US Companies Moving the Markets, Morning edition
Fri, Aug 09, 2024 as of 10.00 am ET
08/09/2024 08:58 AM EDT 24/7 Market News 24/7 Market News- FSD Pharma's Celly Nutrition Project Secures Additional Financing to Launch unbuzzd
08/09/2024 08:30 AM EDT InvestorBrandNetwork InvestorNewsBreaks - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Reports on Status of New Product, Investment in Celly Nutrition Corp.
08/01/2024 10:00 AM EDT QM US Market Movers News US Companies Moving the Markets, Morning edition
Thu, Aug 01, 2024 as of 10.00 am ET
07/25/2024 10:00 AM EDT InvestorBrandNetwork InvestorNewsBreaks - FSD Pharma Inc.'s (NASDAQ: HUGE) (CSE: HUGE) (FRA:0K9A) Revolutionary Rapid Detoxification Drink Spotlighted in 24/7 Market News Report
07/25/2024 08:16 AM EDT 24/7 Market News Functional Beverage Marketing Masters
Page